Mean age, years (SD) | 59 (22.2) | 50 (22.4) | .07a |
Sex (%) | | | .22b+ |
Male | 23 (85) | 94 (72) | |
Female | 4 (15) | 36 (28) | |
Admission blood pressure, mm Hg | | | |
Systolic (SD) | 144.4 (30.5) | 140.0 (26.1) | .50a |
Diastolic (SD) | 76.7 (15.9) | 76.4 (14.7) | .93a |
Mean admission GCS (SD) | 10.2 (4.3) | 11.8 (4.1) | .09c |
History of hypertension (%) | 13 (48) | 33 (25) | .02b |
Mean admission platelet count (SD) | 235.4 (85.5) | 246.2 (68.2) | .47a |
Mean admission INR (SD) | 1.3 (0.8) | 1.2 (0.5) | .27a |
Mean admission aPTT (SD) | 27.4 (6.3) | 25.4 (5.1) | .08a |
Altered coagulation (%) | 2 (7) | 7 (5) | .48b |
Antiplatelet therapy (%) | 6 (22) | 18 (14) | .38b |
Mean initial maximum aSDH width, mm (SD) | 6.9 (3.6) | 5.8 (3.5) | .12a |
Mean initial maximum midline shift, mm (SD) | 0.40 (0.4) | 0.18 (0.3) | .0004a |
Mean time to follow-up NCCT, hours (SD) | 9.58 (7) | 11.28 (7.3) | .29a |